PKTXOTCPharmaceutical PreparationsFiscal year ends December 31
ProtoKinetix, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-K on Sep 3, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $78.61K
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about ProtoKinetix from other investors
No posts about PKTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.